NCDs, Part I: Overview of NCDs, CED, and Potential Access Barriers

Avalere Essential Voice

English - June 16, 2022 15:47 - 13 minutes - 18.5 MB
Medicine Health & Fitness Science Life Sciences Homepage Download Google Podcasts Overcast Castro Pocket Casts RSS feed

Previous Episode: Exploring the Kidney Care Environment, Part III: Addressing Healthcare Disparities

Next Episode: NCDs, Part II: Evidence Development to Fulfill CED Requirements

Tune into the first episode in the Avalere Health Essential Voice podcast series focused on how CMS and Medicare coverage decisions define patient access. In this segment, our Market Access experts discuss national coverage determinations (NCDs), specifically those with coverage with evidence development (CED), their impacts to patient access, and considerations for life sciences companies.